EUVIMEDEUVIMED entdecken
Crossref

Biochanin A alleviates endothelial cell senescence via epigenetic regulation of the HDAC1/H3K4me3/NFKB1 axis

Xiaoying Wang, Qiang Tu, Aiqiu Mao, Kun Meng, Jun Lv, Bo Li, Tangya Zhang, Hui Zhang, Yan Ding, Zheng Cao

Phytomedicine · 2025

DOI: 10.1016/j.phymed.2025.157385 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytomedicine, 2025. Verfasst von Xiaoying Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei 442000, China; Institute of Infection and Immune Diseases, Hube…. Hauptthemen laut MEDLINE: Cellular Senescence, Epigenesis, Genetic, Histone Deacetylase 1, Genistein. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: Innovative Research Group Project of the National Natural Science Foundation of China, Hubei Province Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Aging is a multifaceted physiological and pathological process, with endothelial cell senescence being a pivotal contributor to vascular aging. Biochanin A (BCA), a naturally occurring flavonoid, possesses known anti-inflammatory and antioxidant properties; however, its specific role and mechanism in combating endothelial senescence are not well defined. PURPOSE: This study aimed to investigate the potential anti-senescent effects of BCA on endothelial cells and aged vasculature, and to elucidate the underlying molecular mechanisms. STUDY DESIGN: The study employed a combination of in vitro cellular models and in vivo animal models to assess the effects of BCA on senescence. Mechanistic investigations were conducted to identify key molecular targets and pathways. METHODS: In vitro, an Angiotensin II (Ang II)-induced senescence model in human umbilical vein endothelial cells (HUVECs) was used. In vivo, naturally aged mice were treated with BCA. Senescence markers and SASP factors (e.g., IL-6, IL-8) were evaluated. RNA sequencing was performed to identify potential targets. Histone modification changes were analyzed through genomic binding site analysis, CUT&Tag assays, and chromatin immunoprecipitation quantitative PCR (ChIP-qPCR). Knockdown of histone deacetylase 1 (HDAC1) was achieved using siRNA to verify its necessity. RESULTS: BCA treatment effectively attenuated senescence markers and reduced senescence-associated secretory phenotype (SASP) levels in both Ang II-induced HUVECs and naturally aged mice. RNA sequencing identified HDAC1 as a key target. Mechanistically, BCA upregulated HDAC1, which subsequently suppressed the epigenetic aging marker H3K4me3. CUT&Tag and ChIP-qPCR analyses confirmed that this reduction in H3K4me3 occurred specifically at the promoter region of NFKB1 (p50), leading to its transcriptional downregulation. This inhibition of NFKB1 suppressed NF-κB signaling and the production of SASP factors. Crucially, HDAC1 knockdown completely abolished the anti-senescence benefits of BCA. CONCLUSION: Our findings demonstrate that Biochanin A alleviates endothelial and vascular senescence by targeting the HDAC1/H3K4me3/NFKB1 axis. This epigenetic mechanism inhibits NF-κB-mediated SASP production, positioning BCA as a promising natural epigenetic modulator to restore vascular homeostasis and mitigate age-related vascular dysfunction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cellular SenescenceEpigenesis, GeneticHistone Deacetylase 1GenisteinHumansHuman Umbilical Vein Endothelial CellsAnimalsHistonesMiceMaleMice, Inbred C57BLAngiotensin II

Stichwörter der Autor:innen

Biochanin AEpigeneticsH3K4me3HDAC1Senescence

Substanzen

Histone Deacetylase 1Genisteinbiochanin AHistonesHDAC1 protein, humanAngiotensin II

Autor:innen und Institutionen

  • Department of Cardiology, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei 442000, China; Institute of Infection and Immune Diseases, Hubei Key Laboratory of Embryonic Stem Cell Research, Hubei Provincial Cli…
  • Department of Cardiology, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei 442000, China.
  • Institute of Infection and Immune Diseases, Hubei Key Laboratory of Embryonic Stem Cell Research, Hubei Provincial Clinical Research Center for Umbilical Cord Blood Hematopoietic Stem Cells, Taihe Hospital, Hubei Univer…
  • Department of Cardiology, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei 442000, China. Electronic address: caozheng908@163.com.

Förderung

  • Innovative Research Group Project of the National Natural Science Foundation of China
  • Hubei Province Natural Science Foundation

Zitieren

APA

Wang, X., Tu, Q., Mao, A., Meng, K., Lv, J., Li, B., Zhang, T., Zhang, H., Ding, Y., & Cao, Z. (2025). Biochanin A alleviates endothelial cell senescence via epigenetic regulation of the HDAC1/H3K4me3/NFKB1 axis. Phytomedicine. https://doi.org/10.1016/j.phymed.2025.157385

Vancouver

Wang X, Tu Q, Mao A, Meng K, Lv J, Li B, et al. Biochanin A alleviates endothelial cell senescence via epigenetic regulation of the HDAC1/H3K4me3/NFKB1 axis. Phytomedicine. 2025. doi:10.1016/j.phymed.2025.157385

BibTeX
@article{Wang2025,
  author = {Wang, Xiaoying and Tu, Qiang and Mao, Aiqiu and Meng, Kun and Lv, Jun and Li, Bo and Zhang, Tangya and Zhang, Hui and Ding, Yan and Cao, Zheng},
  title = {Biochanin A alleviates endothelial cell senescence via epigenetic regulation of the HDAC1/H3K4me3/NFKB1 axis},
  journal = {Phytomedicine},
  year = {2025},
  doi = {10.1016/j.phymed.2025.157385}
}
Kostenlos starten →